Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBILB.L Regulatory News (BILB)

  • There is currently no data for BILB

Directorate Change

5 Apr 2019 07:00

RNS Number : 2133V
Bilby PLC
05 April 2019
 

5 April 2019

Bilby plc

("Bilby" or the "Company")

 

Directorate Change

 

Bilby Plc (AIM:BILB), a leading gas heating, electrical and building services provider is pleased to announce the appointment of David Bullen as Chief Executive Officer ("CEO") who will join the Company on 15 April 2019. Simultaneously David Ellingham, the current CEO of Bilby, is stepping down to pursue other career opportunities.

 

David Bullen joins Bilby from Boleyn International Ltd, a strategic management consultancy he founded in 2016. Mr Bullen brings an impressive track record of creating substantial shareholder value as CEO at Anpario plc. David joined Anpario in 2007, moving on to become COO in 2009. He was the CEO between 2011 and 2016 where he oversaw growth in revenue and profits, delivering a four-fold increase in the share price. Prior to Anpario, David spent eight years at Novartis, where he held several senior positions both in the UK and abroad.

 

Bilby also announces as part of its ongoing efforts to meet the highest Corporate Governance standards, it has commenced a search for an additional Non-Executive Director to further enhance the Board.

 

The Directors look forward to working with David and are confident Bilby will benefit from his considerable experience of running multi-divisional companies.

 

Sangita Shah, Chairman of Bilby Plc, commented:

"We are delighted to announce David Bullen is joining Bilby as CEO. He brings with him significant experience of managing a listed company and an impressive track record of delivering growth and margin enhancement. We believe he is an excellent fit for Bilby and we look forward to working with him, restoring stakeholder confidence in Bilby and strengthening its market position.

 

Since listing in 2015 David Ellingham has served on the Bilby board and has played a key role in the buy and build strategy and successfully acquired four strong businesses. We wish him well in the future."

 

Commenting on his appointment, David Bullen said:

"I am excited to take the helm of a service-led business that has such a breadth of great people as its foundation. The business will continue to focus on providing a best in class service to our customers, driving further efficiencies to improve our operational excellence and capitalising on the vast potential our sector offers. I believe the outlook for the group is positive and I look forward to delivering success for all stakeholders."

 

Schedule 2(g) Disclosures

 

The following information is disclosed pursuant to Rule 17 and Schedule Two Paragraph (g) of the AIM Rules for Companies.

 

David Michael Alexander Bullen, aged 46, has held the following current and previous directorships in the last 5 years:

 

Current directorships and/or partnerships:

Former directorships and/or partnerships (within the last five years):

Boleyn International Ltd

 

Anpario plc

Anpario UK Ltd

Kiotechagil Ltd

Meriden Animal Health Ltd

Orego-Stim Ltd

 

Save as disclosed above, there are no further disclosures required to be made in respect of the appointment under Schedule 2(g) or Rule 17 of the AIM Rules for Companies.

 

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) 596/2014. Market soundings, as defined in MAR, were taken in respect of the share sale with the result that certain persons became aware of inside information, as permitted by MAR. That inside information is set out in this announcement and has been disclosed as soon as possible in accordance with paragraph 7 of article 17 of MAR. Therefore, those persons that received inside information in a market sounding are no longer in possession of inside information relating to the Group and its securities.

 

 

Enquiries

 

Bilby plc

 

David Bullen, Chief Executive Officer

 

 

+44 (0)20 7796 4133

(via Hudson Sandler)

 

 

Canaccord Genuity Ltd (Nominated Adviser and Joint Broker)

+44 (0)20 7523 8000

Corporate Broking:

Bobbie Hilliam

Georgina McCooke

Sales:

Jonathan Barr

 

 

 

Stanford Capital Partners (Joint Broker)

Patrick Claridge

 

Sales:

John Howes

Bob Pountney

 

+44 (0)20 3815 8880

 

 

Hudson Sandler (Financial PR)

+44 (0)20 7796 4133

Charlie Jack

Bertie Berger

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOADMGGDNDDGLZM
Date   Source Headline
24th Sep 20197:00 amRNSUpdate re Director
19th Sep 20197:00 amRNSFull Year Results
1st Aug 20197:00 amRNSTrading update
11th Jul 20194:44 pmRNSChange of Registered Office/Co-Sec
5th Apr 20197:00 amRNSDirectorate Change
18th Mar 20197:00 amRNSAppointment of COO
5th Mar 20194:41 pmRNSSecond Price Monitoring Extn
5th Mar 20194:35 pmRNSPrice Monitoring Extension
5th Mar 20197:00 amRNSTrading Update
21st Jan 20191:08 pmRNSPayment of Dividend
12th Dec 201810:38 amRNSDirector/PDMR Shareholding
11th Dec 20187:00 amRNSInterim Results
29th Nov 20187:00 amRNSAcquisition of R. Dunham
7th Nov 20187:00 amRNSAppointment of Finance Director and Nomad
11th Sep 20185:52 pmRNSResult of AGM & Payment of Final Dividend
7th Sep 201811:34 amRNSHolding(s) in Company
6th Sep 20183:58 pmRNSReplacement: Holding(s) in Company
5th Sep 201811:09 amRNSHolding(s) in Company
4th Sep 20184:31 pmRNSHolding(s) in Company
4th Sep 20187:00 amRNSSale of Founder's Shares and Board Changes
6th Aug 201812:57 pmRNSReplacement: Annual Report and Notice of AGM
2nd Aug 20182:02 pmRNSAnnual Report and Notice of AGM
16th Jul 20181:25 pmRNSUnaudited Preliminary Results
10th May 20188:18 amRNSHolding(s) in Company
23rd Apr 20187:00 amRNSHolding(s) in Company
5th Apr 201811:23 amRNSHolding(s) in Company
21st Feb 20187:00 amRNSTrading update
31st Jan 201811:31 amRNSNotice of General Meeting
24th Jan 20182:30 pmRNSPayment of Interim Dividend
17th Jan 20187:00 amRNSStatement re: CarillionAmey Limited
12th Jan 20182:08 pmRNSShareholder Circular and Notice of General Meeting
21st Dec 20173:39 pmRNSPayment of Historic Dividends and General Meeting
21st Nov 20177:00 amRNSInterim Results
27th Sep 20173:29 pmRNSSpokemead Maintenance Limited Consideration
15th Sep 201710:01 amRNSHolding(s) in Company
4th Aug 201710:29 amRNSResult of AGM
20th Jul 20174:55 pmRNSHolding(s) in Company
20th Jul 20172:49 pmRNSHolding(s) in Company
14th Jul 20177:00 amRNSLoan Note, Grant of Options and Issue of Shares
13th Jul 20177:00 amRNSAnnual Report, Notice of AGM & DCB Consideration
26th Jun 20177:00 amRNSPreliminary Results
15th May 20177:00 amRNSTrading Update
12th Apr 20177:00 amRNSPre-close Trading Update and Change of Adviser
21st Dec 20164:30 pmRNSHolding(s) in Company
20th Dec 20169:43 amRNSDividend Timetable
16th Dec 20167:01 amRNSDirectorate Changes
16th Dec 20167:00 amRNSHalf-year Report
8th Dec 201611:05 amRNSSecond Price Monitoring Extn
8th Dec 201611:00 amRNSPrice Monitoring Extension
7th Dec 20162:25 pmRNSRestatement of Prior Year Financial Statements

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.